Fengjiao J. Huang
197 Ruijin 2nd Road
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Mettl14-mediated m6A modification of lncRNA Gm2824 regulates GLP-1 secretion via the YBX1/Foxa1 pathway in type 2 diabetic mice.
Journal: Journal of endocrinological investigation
Published: February 13, 2026
A case of 11β-hydroxylase deficiency complicated with bilateral adrenal myelolipoma
Journal: Zhonghua nei ke za zhi
Published: January 25, 2025
NrCAM activates the NF-κB signalling pathway by competitively binding to SUMO-1 and promotes Th17 cell differentiation in Graves' disease.
Journal: Scandinavian journal of immunology
Published: March 14, 2024
A role of NR4A2 in Graves' disease: regulation of Th17/Treg.
Journal: Endocrine
Published: May 07, 2023
A curtain purification system based on a rabbit fur-based rotating triboelectric nanogenerator for efficient photocatalytic degradation of volatile organic compounds.
Journal: Nanoscale
Published: March 20, 2023
Clinical characteristics of familial dysalbuminemic hyperthyroxinemia in Chinese patients and comparison of free thyroxine in three immunoassay methods.
Journal: Frontiers in endocrinology
Published: November 19, 2022
Simultaneous determination of vitamin D metabolites 25(OH)D3 and 1α,25(OH)2D3 in human plasma using liquid chromatography tandem mass spectrometry.
Journal: Journal of mass spectrometry and advances in the clinical lab
Published: November 03, 2021
LncRNA FENDRR promotes apoptosis of Leydig cells in late-onset hypogonadism by facilitating the degradation of Nrf2.
Journal: Cell and tissue research
Published: January 11, 2021
lncRNA:mRNA expression profile in CD4+ T cells from patients with Graves' disease.
Journal: Endocrine connections
Published: September 29, 2020
Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves' disease.
Journal: Journal of translational medicine
Published: April 13, 2018
MicroRNA-4443 Causes CD4+ T Cells Dysfunction by Targeting TNFR-Associated Factor 4 in Graves' Disease.
Journal: Frontiers in immunology
Published: July 28, 2017
Last Updated: 09/26/2026